GCC· 1 min read
India can build healthcare AI. Can its GCCs own the outcomes?
India's 40+ healthcare GCCs are moving into AI drug discovery and clinical data science. Here's why ownership, validation and outcome metrics must follow.
79,000
professionals in India's healthcare GCCs
Zinnov's latest article puts that question in focus:
- India has 40+ healthcare GCCs, 65+ GCC units and around 79,000 professionals working across areas including R&D, engineering, clinical data and healthcare operations.
- Work is expanding into AI drug discovery, connected devices and clinical data science.
- Ownership needs to follow. India teams need decision rights, funding and accountability alongside their technical responsibilities.
- Build trust early. Clinical validation and testing across different patient populations belong inside product development.
- Track the outcomes. Measure products deployed, capacity created and improvements in quality.
How we would start
At Nivasoft, we'd start with one healthcare workflow, connect the relevant data securely and agree who owns validation and the outcome before the team begins building. Our GCC setup and enterprise AI services support that foundation.
Source: Zinnov Healthcare Think Tank Session, Confluence 2026.
- Healthcare AI
- GCC
- Enterprise AI